Metabolomic Signatures of Autoimmune Hepatitis in the Development of Cirrhosis

Frontiers in Medicine

Ying Huang¹  Shuai-shuai Chen¹  Xiao-he Xiao¹  Zi-teng Zhang¹  Zheng-sheng Zou¹  Ge-zi Shi¹  Jing Jing¹  Jia-bo Wang²  Ming Niu³  Yue-cheng Yu⁴  Hai-zhu Zhang⁵  Xian He⁶  Shan-shan Li⁶ 

[1] Department of Liver Diseases, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China;Department of Liver Diseases, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China;School of Traditional Chinese Medicine, Capital Medical University, Beijing, China;Department of Poisoning Treatment, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China;Liver Diseases Center of General Hospital of PLA Eastern Theater Command, Bayi Hospital Affiliated to Nanjing University of Chinese Medicine, Nanjing, China;School of Pharmacy and Chemistry, Dali University, Dali, China;School of Pharmacy and Chemistry, Dali University, Dali, China;Department of Liver Diseases, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China;

关键词: liver cirrhosis;    autoimmune hepatitis;    metabolomics;    metabolic pathway;    biomarkers;   

DOI  :  10.3389/fmed.2021.644376

来源: Frontiers

【 授权许可】

CC BY